MeCP2 Gene Therapy Ameliorates Disease Phenotype in Mouse Model for Pitt Hopkins Syndrome

0
57
Researchers discovered that MeCP2 levels were decreased in PTHS patient iNPCs relative to healthy controls and that both iNPCs and iAstrocytes displayed defects in function and differentiation in a mutation-specific manner.
[Neurotherapeutics]
Abstract